Femasys (FEMY) EBIT (QoQ) (2020 - 2025)
Powered by 
Analysis
Femasys (FEMY) EBIT (QoQ) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.55 Bn | 175.95 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.61 Bn | 122.40 Bn | 1.96 Bn |
| 3 | Medtronic | 117.18 Bn | 108.37 Bn | 6.34 Bn |
| 4 | Stryker | 105.17 Bn | 101.69 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.67 Bn | 64.13 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn |
| 10 | Femasys | 9.52 Mn | 8.07 Mn | 189,391.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 29.47% |
| Mar 31, 2025 | -15.63% |
| Dec 31, 2024 | 7.73% |
| Sep 30, 2024 | -14.20% |
| Jun 30, 2024 | -29.44% |
| Mar 31, 2024 | 22.18% |
| Dec 31, 2023 | -9.02% |
| Sep 30, 2023 | -39.01% |
| Jun 30, 2023 | 3.48% |
| Mar 31, 2023 | -1.38% |
| Dec 31, 2022 | 1.86% |
| Sep 30, 2022 | -14.93% |
| Jun 30, 2022 | 7.73% |
| Mar 31, 2022 | -22.27% |
| Dec 31, 2021 | -4.72% |
| Sep 30, 2021 | -18.43% |
| Jun 30, 2021 | -4.08% |
| Mar 31, 2021 | -9.74% |
| Dec 31, 2020 | -6.36% |
| Sep 30, 2020 | -5.48% |